Intelligence Unit Special Reports Special Events Subscribe Sponsored Departments Follow Us

Twitter Facebook LinkedIn RSS

Study: HPV vaccine by age 21 a sound public health investment

USA Today, August 21, 2008
A new economic analysis shows that the HPV vaccine could be a good financial investment in public health if given to preadolescent girls and women up to age 21. Authors of the study measured the Gardasil vaccine's value by calculating the cost of giving one person an extra healthy year of life and balancing the expense of vaccinations with the benefits of avoiding cancer, death, and related expenses.